Toff
Well-known member
Im seeing the share prices plummet for GTX and fund managers advice to steer clear from the companies shares (and ignore MD’s advice that Ostarine will pass clinical trials in a desperate attempt to keep the company afloat) however, despite these failures to pass POWER 1&2 trials im struggling to get the facts on what it could do for the likes of us (ie, normal healthy adults.)
The FDA cannot offer a license based on the pre-agreed requirements (muscle mass AND extension of life) – it seems from the facts the enobosarm passed muscle mass test but failed to prove it extended cancer patients life due to the muscle mass (at 3mg daily).
So, my point is, has it passed safety trials (and thus avoid US turning into a cancer patient!), does it increase LMM and so, worth the investment from this point of view and can you indeed get it FOR REAL on the market (or is it all bunk PH/REAL juice passed off as Ostarine).
The FDA cannot offer a license based on the pre-agreed requirements (muscle mass AND extension of life) – it seems from the facts the enobosarm passed muscle mass test but failed to prove it extended cancer patients life due to the muscle mass (at 3mg daily).
So, my point is, has it passed safety trials (and thus avoid US turning into a cancer patient!), does it increase LMM and so, worth the investment from this point of view and can you indeed get it FOR REAL on the market (or is it all bunk PH/REAL juice passed off as Ostarine).